Peter F. Billingsley
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$12.8MFederal grants as PI19 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
19 awards · $12.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 1, 2024 | NIH | SBIR Phase I Conditional male lethal Anopheles stephensi line for the efficient manufacture of malaria vaccines | $300K | SANARIA INC. |
| Mar 29, 2023 | NIH | SBIR Phase II A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products | $1.0M | SANARIA INC. |
| Feb 14, 2023 | NIH | SBIR Phase I Conditional male lethal Anopheles stephensi line for the efficient manufacture of malaria vaccines | $300K | SANARIA INC. |
| Mar 28, 2022 | NIH | SBIR Phase II A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products | $1.0M | SANARIA INC. |
| Jan 7, 2022 | NIH | SBIR Phase II Cryopreservation of Anopheles Embryos | $967K | SANARIA INC. |
| Apr 15, 2021 | NIH | SBIR Phase II A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products | $1.0M | SANARIA INC. |
| Mar 25, 2021 | NIH | SBIR Phase II Cryopreservation of Anopheles Embryos | $962K | SANARIA INC. |
| Feb 18, 2020 | NIH | SBIR Phase II Cryopreservation of Anopheles Embryos | $1000K | SANARIA INC. |
| Feb 14, 2020 | NIH | SBIR Phase I Genetically Modified Conditional Sexing A. stephensi Line for PfSPZ Manufacture | $298K | SANARIA INC. |
| Jul 22, 2019 | NIH | SBIR Phase II Immune Deficient Mosquitoes for Improved Malaria Sporozoite Vaccine Manufacture | $966K | SANARIA INC. |
| Jun 12, 2019 | NIH | SBIR Phase I A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products. | $300K | SANARIA INC. |
| Mar 7, 2019 | NIH | SBIR Phase I Genetically Modified Conditional Sexing A. stephensi Line for PfSPZ Manufacture | $296K | SANARIA INC. |
| Jul 18, 2018 | NIH | SBIR Phase II Immune Deficient Mosquitoes for Improved Malaria Sporozoite Vaccine Manufacture | $982K | SANARIA INC. |
| Jul 18, 2018 | NIH | SBIR Phase I A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products. | $300K | SANARIA INC. |
| Aug 2, 2017 | NIH | SBIR Phase II Immune Deficient Mosquitoes for Improved Malaria Sporozoite Vaccine Manufacture | $999K | SANARIA INC. |
| Jul 18, 2016 | NIH | SBIR Phase II Cryopreservation of Anopheles Embryos | $497K | SANARIA INC. |
| Jan 28, 2016 | NIH | SBIR Phase I Development of a whole parasite Plasmodium falciparum sexual and mosquito stages Vaccine to Interrupt Malaria Transmission | $313K | SANARIA INC. |
| Jun 29, 2015 | NIH | SBIR Phase II Cryopreservation of Anopheles Embryos | $981K | SANARIA INC. |
| Feb 18, 2015 | NIH | SBIR Phase I Development of a whole parasite Plasmodium falciparum sexual and mosquito stages Vaccine to Interrupt Malaria Transmission | $301K | SANARIA INC. |
Peer ranks
Federal funding#33
Awards as PI#21
Patents#273
Companies
- SANARIA INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.